Category: Cardiopulmonary & Thoracic

Cardiopulmonary & Thoracic

COPD and Asthma Can Delay Lung Cancer Diagnosis by Masking Early Symptoms

Patients with chronic conditions like COPD and asthma are diagnosed with lung cancer significantly later than those without these conditions.

Cardiopulmonary & Thoracic

FDA Grants Orphan Drug Status to Lung Cancer Antibody-Drug Conjugate

The investigational therapy, targeting the B7-H3 antigen, has shown promising tumor-killing effects and a good safety profile in preclinical models.

Cardiopulmonary & Thoracic

New Drug Target Found for Lung Cancer in Never-Smokers

Researchers have identified overactive estrogen signaling as a driver in some never-smoking lung cancer cases, proposing the drug saracatinib as a potential targeted therapy.

Pulmonary Hypertension

FDA Approves Merck’s Injection for Pulmonary Arterial Hypertension

The injection on top of background therapy significantly improved exercise capacity and multiple secondary outcome measures compared to background therapy alone.

Pulmonary Embolism

FDA Clears AlphaVac F1885 System for Treatment of Pulmonary Embolism

The clearance broadens the applicability of the AlphaVac F1885 System in the non-surgical removal of thrombi or emboli from the venous vasculature.

Thoracic Surgery

Patients May Receive Unrealistic Recovery Timelines for Robotic Lung Surgery

A study surveying patients who underwent robotic lung surgery found that many experience longer healing times than the commonly advised six-week recovery period.

Lung Cancer

Lung Cancer Cells Less Affected by Cigarette Smoke Than Healthy Cells

New research may have revealed how lung cancer cells can persist in smoke. The mechanism could be related to how cancer cells develop resistance to pharmaceutical treatments as well.